Back to search
FDAFDA · Food and drugs·Recall number D-808-2013

Pharmalucence Kit for the Preparation of Technetium Tc 99m Sestamibi Injection for Mycardial and Breast Imaging. For Intravenous Use and Reconstitution. a) Five vials kits: NDC# 45567-0555-1, b) Thirty vials kits: NDC# 45567-0555-2, Rx Only, Manufactured by: Pharmalucence, Inc., Billerica, MA 01821

Published July 31, 2013 · Recall initiated: May 30, 2013

Summary

FDA records drug Class III recall D-808-2013, published July 31, 2013 and initiated May 30, 2013. Recalling firm: Pharmalucence, Inc.; Status: Terminated; Reported quantity: 17,260 vials; Lot: Lot 280011, Exp 08/13. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter; particulate found in retain samples

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmalucence, Inc.
Distributor
Nationwide & Bahamas, Barbados, Bermuda, Japan
Lot
Lot 280011, Exp 08/13
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pharmalucence Kit for the Preparation of Technetium Tc 99m Sestamibi Injection for Mycardial and Breast Imaging. For Intravenous Use and Reconstitution. a) Five vials kits: NDC# 45567-0555-1, b) Thirty vials kits: NDC# 45567-0555-2, Rx Only, Manufactured by: Pharmalucence, Inc., Billerica, MA 01821 recalled?

Yes. FDA published recall D-808-2013 on July 31, 2013. Reported hazard: Presence of Particulate Matter; particulate found in retain samples

What should I do if I have this product?

Voluntary: Firm initiated · Letter